References
- Bousquet J, Jeffery P K, Busse W W, Johnson M, Vignola A M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161(5)1720–1745, [PUBMED], [INFOTRIEVE], [CSA]
- NIH. National Asthma Education and Prevention Program Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. NIH publication 97‐4051, National Heart, Lung and Blood Institute, Bethesda, MD 1997; 1–52
- Weiss K B, Sullivan S D. The health economics of asthma and rhinitis I. Assessing the economic impact. J Allergy Clin Immunol 2001; 107(1)3–8, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chan‐Yeung M, Chang J H, Manfreda J, Fergueson A, Becker A. Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma. Am J Respir Crit Care Med 1996; 154(4)889–893, [CSA]
- Kikuchi Y, Okabe S, Tamura G, Hida W, Homma M, Shirato K, Takishima T. Chemosensitivity and perception of dyspnea in patients with a history of near‐fatal asthma. N Engl J Med 1994; 330(19)1329–1334, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lim S, Jatakanon A, John M, Gilbey T, O'Conner B J, Chung K F, Barnes P. Effect of inhaled budesonide on lung function and airway inflammation. Am J Respir Crit Care Med 1999; 159(1)22–30, [PUBMED], [INFOTRIEVE], [CSA]
- Alving K, Weitberg E, Lundberg J M. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6(9)1368–1370, [PUBMED], [INFOTRIEVE]
- Kharitonov S A, Yates D, Springall D R, Buttery L, Polak J, Robbins R A, Barnes P J. Exhaled nitric oxide is increased in asthma. Chest 1995; 107(3 Suppl)156S–157S, [PUBMED], [INFOTRIEVE]
- Kharitonov S A, Yates D, Robbins R A, Logan‐Sinclair R, Shinebourne E A, Barnes P J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343(8890)133–135, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pin I, Gibson P G, Kolendowicz R, Girgis‐Gabardo A, Denburg J A, Hargreave F E, Dolovich J. Use of induced sputum cell count to investigate airway inflammation in asthma. Thorax 1992; 47(1)25–29, [PUBMED], [INFOTRIEVE]
- Oddera S, Silvestri M, Balbo A, Jovovich B O, Penna R, Crimi E, Rossi G A. Airway eosinophilic inflammation, epithelial damage, and bronchial hyperresponsiveness in patients with mild‐moderate stable asthma. Allergy 1996; 51(2)100–107, [PUBMED], [INFOTRIEVE], [CSA]
- Leuppi J D, Salome C M, Jenkins C R, Anderson S D, Xuan W, Marks G B, Koskela H, Brannan J D, Freed R, Andersson M, Chan H K, Woolcoock A J. Predictive marker of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 2001; 163(2)406–412, [PUBMED], [INFOTRIEVE], [CSA]
- Silkoff P E, McClean P A, Slutsky A S, Caramori M, Chapman K R, Gutierrez C, Zamel N. Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma. J Asthma 1998; 35(6)473–479, [PUBMED], [INFOTRIEVE]
- American Thoracic Society. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med 1999; 160(6)2104–2117, [CSA]
- Deykin A, Massaro A F, Drazen J M, Isreal E. Exhaled nitric oxide as a diagnostic test for asthma: online versus offline technique and effect of flow rate. Am J Respir Crit Care Med 2002; 165(12)1597–1601, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152(3)1107–1136, [CSA]
- Cowie R L, Underwood M F, Revitt S F, Field S K. Predicting emergency department utilization in adults with asthma: a cohort study. J Asthma 2001; 38(2)179–184, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cowie R L, Underwood M F, Revitt S F, Field S K. Asthma lifestyle score—the value of patient self‐assessment in asthma. Am J Respir Crit Care Med 2001; 163(5)A318
- Kharitonov S A, Barnes P J. Clinical aspects of exhaled nitric oxide. Eur Respir J 2000; 16(4)781–792, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sippel J M, Holden W E, Tilles S A, O'Hallaren M, Cook J, Thukkani N, Priest J, Nelson B, Osborne M L. Exhaled nitric oxide levels correlate with measures of disease control in asthma. J Allergy Clin Immunol 2000; 106(4)645–650, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jones S L, Kittelson J, Cowan J O, Flannery E M, Hancox R J, McLachlan C R, Taylor D R. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001; 164(5)738–743, [PUBMED], [INFOTRIEVE], [CSA]
- Bates C A, Silkoff P E. Exhaled nitric oxide in asthma: from bench to bedside. J Allergy Clin Immunol 2003; 111(2)256–262, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Beck‐Ripp J, Girese M, Arenz S, Koring C, Pasqualoni B, Bufler P. Changes in exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J 2002; 19: 1015–1019, [CROSSREF]
- Kharitonov S A, Yates D H, Chung K F, Barnes P J. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 1996; 9(2)196–201, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kharitonov S A, Donnelly L E, Montuschi P, Corradi M, Collins J V, Barnes P J. Dose‐dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 2002; 57(10)889–896, [PUBMED], [INFOTRIEVE], [CROSSREF]